THE DEAL, AT A GLANCE
From the announcementCelaid Therapeutics Completes Second
01Who is involvedBacked by Investors [From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedCelaid Therapeutics Completes Second raised Series B, announced 2026-10-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersCelaid Therapeutics' Series B financing supports CLD-001 manufacturing, safety assessment, clinical development, regulatory activities, its IND application, and the…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Celaid Therapeutics Completes Second · Financing Record
Explore source-linked visual explanations for Celaid Therapeutics Completes Second. Unsupported claims are withheld while source review continues.
Record 13391 · Recorded date: 2026-10-05
Explore company records →